Cronos (CRON) Non-Current Deferred Tax Liability (2016 - 2026)
Cronos' (CRON) quarterly Non-Current Deferred Tax Liability came in at $4.0 million in Q1 2026, down 12.69% year-on-year from $4.6 million in Q1 2025, and down 2.57% quarter-over-quarter from $4.1 million in Q4 2025.
Cronos (CRON) Non-Current Deferred Tax Liability (2016 - 2026) Analysis & Trends
Cronos' Non-Current Deferred Tax Liability history runs 9 years deep, the most recent figure standing at $4.0 million for Q1 2026.
- On a quarterly basis, Non-Current Deferred Tax Liability fell 12.69% year-over-year to $4.0 million in Q1 2026; TTM through Mar 2026 was $4.0 million, a 12.69% decrease from a year earlier, with the FY2025 full-year figure at $4.1 million, up 14.73% from the prior year.
- Non-Current Deferred Tax Liability fell to $4.0 million in Q1 2026 per CRON's latest filing, from $4.1 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $11.1 million in Q3 2024 and bottomed at $46000.0 in Q2 2022.
- The 5-year median for Non-Current Deferred Tax Liability is $3.4 million (2025), against an average of $3.1 million.
- Across the five-year window, Non-Current Deferred Tax Liability jumped 1869.06% in 2024 and sank 69.22% in 2025, its largest moves.
- Year by year, Non-Current Deferred Tax Liability stood at $1.9 million in 2022, then slumped by 90.56% to $181000.0 in 2023, then soared by 1869.06% to $3.6 million in 2024, then climbed by 14.73% to $4.1 million in 2025, then retreated by 2.57% to $4.0 million in 2026.
- Per Business Quant, the three latest CRON Non-Current Deferred Tax Liability figures stand at $4.0 million (Q1 2026), $4.1 million (Q4 2025), and $3.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Cronos | 1.08 Bn | 261.26 Mn | 19.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.98 Mn |
| Mar 31, 2026 | 3.98 Mn |
| Dec 31, 2025 | 4.09 Mn |
| Dec 31, 2025 | 4.09 Mn |
| Sep 30, 2025 | 3.43 Mn |
| Sep 30, 2025 | 3.43 Mn |
| Jun 30, 2025 | 5.54 Mn |
| Jun 30, 2025 | 5.54 Mn |
| Mar 31, 2025 | 4.56 Mn |
| Mar 31, 2025 | 4.56 Mn |
| Dec 31, 2024 | 3.56 Mn |
| Dec 31, 2024 | 3.56 Mn |
| Sep 30, 2024 | 11.14 Mn |
| Sep 30, 2024 | 11.14 Mn |
| Dec 31, 2023 | 181,000.00 |
| Dec 31, 2023 | 181,000.00 |
| Jun 30, 2023 | 675,000.00 |
| Jun 30, 2023 | 675,000.00 |
| Mar 31, 2023 | 378,000.00 |
| Mar 31, 2023 | 378,000.00 |